Deimos Asset Management’s Pfizer PFE Stock Holding History

Deimos Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-54,808	Closed	-$1.68M	–	141
2015 Q4	$1.68M	Buy	+54,808	New	+$1.72M	1.01%	24

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Deimos Asset Management's PFE Position: Q1 2016 in Review

Deimos Asset Management sold out of Pfizer (PFE) in Q1 2016, closing a stake of 54,808 shares — an estimated $1.68M sold.

Deimos Asset Management first reported a position in PFE in Q4 2015 and held it in 1 quarter. The position peaked at $1.68M in Q4 2015. 1,967 funds tracked by Wall St. Rank hold PFE as of Q1 2016.

Deimos Asset Management reported no remaining Pfizer position as of Q1 2016 after selling out during the quarter.
Deimos Asset Management sold 54,808 Pfizer shares in Q1 2016, an estimated $1.68M.
Deimos Asset Management first reported a position in Pfizer in Q4 2015 and held it in 1 quarter.
Deimos Asset Management's Pfizer position peaked at $1.68M in Q4 2015.
1,967 funds tracked by Wall St. Rank held Pfizer as of Q1 2016.

Based on Deimos Asset Management's 13F filing for Q1 2016, filed 13 May 2016.